Clinical trials of metastatic castration-sensitive prostate cancer: Recent progress and new horizons Review
| Authors: | Hamid, A. A.; Morris, M. J.; Davis, I. D. |
| Review Title: | Clinical trials of metastatic castration-sensitive prostate cancer: Recent progress and new horizons |
| Abstract: | Recent clinical trials have changed the treatment landscape for metastatic castration-sensitive prostate cancer. Ongoing and future studies using new therapeutic approaches hold the promise of further improving outcomes for patients with advanced prostate cancer. © 2018 European Association of Urology |
| Keywords: | cancer survival; prednisone; cancer recurrence; cancer combination chemotherapy; cancer risk; drug efficacy; treatment duration; quality of life; prevalence; docetaxel; prostate cancer; cost effectiveness analysis; quantitative analysis; long term care; drug bioavailability; androgen deprivation therapy; clinical trial (topic); phase 2 clinical trial (topic); abiraterone; cancer prognosis; disease burden; human; article; metastatic castration sensitive prostate cancer |
| Journal Title: | European Urology Focus |
| Volume: | 5 |
| Issue: | 2 |
| ISSN: | 2405-4569 |
| Publisher: | Elsevier B.V. |
| Date Published: | 2019-03-01 |
| Start Page: | 165 |
| End Page: | 167 |
| Language: | English |
| DOI: | 10.1016/j.euf.2018.12.001 |
| PUBMED: | 30559064 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 May 2019 -- Source: Scopus |
